Mutual Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $500K | Buy |
888
+50
| +6% | +$28.2K | 0.01% | 777 |
|
|
2025
Q1 | $505K | Sell |
838
-137
| -14% | -$82.6K | 0.01% | 706 |
|
|
2024
Q4 | $676K | Sell |
975
-200
| -17% | -$139K | 0.02% | 603 |
|
|
2024
Q3 | $1.09M | Buy |
1,175
+212
| +22% | +$197K | 0.03% | 454 |
|
|
2024
Q2 | $1.04M | Buy |
963
+7
| +0.7% | +$7.54K | 0.03% | 479 |
|
|
2024
Q1 | $920K | Sell |
956
-739
| -44% | -$711K | 0.03% | 497 |
|
|
2023
Q4 | $1.49M | Sell |
1,695
-359
| -17% | -$315K | 0.05% | 336 |
|
|
2023
Q3 | $1.69M | Buy |
2,054
+1,242
| +153% | +$1.02M | 0.07% | 288 |
|
|
2023
Q2 | $583K | Sell |
812
-52
| -6% | -$37.4K | 0.02% | 589 |
|
|
2023
Q1 | $710K | Buy |
864
+68
| +9% | +$55.9K | 0.03% | 523 |
|
|
2022
Q4 | $574K | Buy |
796
+3
| +0.4% | +$2.16K | 0.03% | 549 |
|
|
2022
Q3 | $546K | Buy |
793
+82
| +12% | +$56.5K | 0.03% | 534 |
|
|
2022
Q2 | $420K | Buy |
711
+20
| +3% | +$11.8K | 0.03% | 590 |
|
|
2022
Q1 | $483K | Buy |
691
+7
| +1% | +$4.89K | 0.03% | 580 |
|
|
2021
Q4 | $432K | Buy |
684
+46
| +7% | +$29.1K | 0.02% | 620 |
|
|
2021
Q3 | $386K | Sell |
638
-25
| -4% | -$15.1K | 0.02% | 631 |
|
|
2021
Q2 | $370K | Buy |
+663
| New | +$370K | 0.02% | 623 |
|
|
2020
Q3 | – | Sell |
-1,125
| Closed | -$702K | – | 696 |
|
|
2020
Q2 | $702K | Buy |
+1,125
| New | +$702K | 0.07% | 292 |
|